Tilray | TRLY - Credores Comerciais

Preço das Ações
8.31
Mudança Diária
-0.65 -7.25%
Mensal
-0.48%
Anual
1,122.06%
Q2 Previsão
9.04




Credores Comerciais Alterar Data
Acasti Pharma USD 459K 881K 2025-09
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alaunos Therapeutics USD 843K 34K 2025-09
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Avita Medical AUD 8.96M 1.69M 2025-12
Canopy Growth CAD 19.96M 1.83M 2025-12
Cronos Group USD 11.64M 775K 2025-12
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
IQVIA Holdings USD 3.75B 201M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Moderna USD 317M 50M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Organon & Co USD 1.07B 7M 2025-09
Revvity USD 185.46M 9.66M 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
Tilray USD 114.5M 3.69M 2025-09
Viatris USD 1.33B 6.4M 2025-09
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12
Zealand Pharma A/S 346.6M 102.71M 2025-12